Scarica l'app Stockscreener
610.64
2.39%
-14.96
Dopo l'orario di chiusura:
610.64
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché REGN Giù?
Forum
Previsione
Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Short Interest Update - MarketBeat
May 23rd Options Now Available For Regeneron Pharmaceuticals (REGN) - Nasdaq
Bernstein Adjusts PT on Regeneron Pharmaceuticals to $979 From $1,010, Maintains Outperform Rating - MarketScreener
Bernstein cuts Regeneron stock price target to $979, maintains Outperform By Investing.com - Investing.com UK
Geode Capital Management LLC Raises Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Allstate Corp Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
California Public Employees Retirement System Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Pictet Asset Management Holding SA - MarketBeat
DnB Asset Management AS Acquires 2,685 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Rep. Robert Bresnahan, Jr. Sells Off Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Follicular Lymphoma Market to Reach New Heights in Growth - openPR.com
Is Regeneron Pharmaceuticals, Inc. (REGN) The Most Profitable Biotech Stock To Buy Right Now? - Insider Monkey
Follicular Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Roche, BeiGene, Kite Pharma, Incyte Corp, AstraZeneca, MEI Pharma, Novartis, Innovent Biologics, Regeneron - Barchart.com
Groupama Asset Managment Increases Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Trexquant Investment LP Acquires 42,674 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Schroder Investment Management Group Sells 13,477 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Alliancebernstein L.P. - MarketBeat
WINTON GROUP Ltd Sells 755 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Sei Investments Co. Trims Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron stock touches 52-week low at $617.71 amid market shifts By Investing.com - Investing.com South Africa
Regeneron stock touches 52-week low at $617.71 amid market shifts - Investing.com Australia
690 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Sava Infond d.o.o. - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 12-Month Low Following Analyst Downgrade - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Lowered to $1,000.00 at JPMorgan Chase & Co. - MarketBeat
The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals - Yahoo Finance
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Franklin Resources Inc. - MarketBeat
Cannell & Spears LLC Has $11.44 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Summit Financial LLC Has $7.50 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
AIA Group Ltd Increases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Leerink Partners Adjusts PT on Regeneron Pharmaceuticals to $780 From $834, Keeps Outperform Rating - MarketScreener
EntryPoint Capital LLC Takes $330,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 12-Month Low After Analyst Downgrade - Defense World
NEOS Investment Management LLC Grows Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Loomis Sayles & Co. L P Purchases 393,997 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
PCSK9 Inhibitor Market Trade Analysis and Statistical Forecast - openPR.com
Intellia Focuses on Pipeline Development Amid Stiff Competition - Yahoo Finance
JPMorgan Adjusts PT on Regeneron Pharmaceuticals to $1,000 From $1,100, Maintains Overweight Rating - Marketscreener.com
RWA Wealth Partners LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Norges Bank Purchases New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (REGN): Among Blue Chip Stocks to Invest in at 52-Week Lows - Insider Monkey
UniSuper Management Pty Ltd Has $5.20 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Prudential Financial Inc. Sells 10,529 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Murphy & Mullick Capital Management Corp Purchases Shares of 444 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Reduced by UNIVEST FINANCIAL Corp - MarketBeat
TD Asset Management Inc. Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN): An Enticing Stock To Watch - stocksregister.com
Nomura Asset Management Co. Ltd. Has $65.90 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week LowHere's What Happened - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 12-Month LowWhat's Next? - MarketBeat
StockWatch: Will Trump Tariffs Return Biopharma Manufacturing to the U.S.? - Genetic Engineering & Biotechnology News
$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today - Benzinga
Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors - Benzinga India
Regeneron (NASDAQ:REGN) and Sanofi Get Japan Green Light for Smokers’ Lung Disease Treatment - TipRanks
1.10%
1.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):